Search - tctmd.com

Displaying 161 - 180 of 193

Sort: Relevancy | Date

News Industry News

FDA approves new antiplatelet drug used during heart procedure

June 24, 2015

News Daily News

Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI

Todd Neale

May 11, 2015

News Daily News

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

L.A. McKeown

April 28, 2015

News Conference News ACC 2015

Long-Term DAPT with Ticagrelor Reduces Ischemic Risk, Ups Bleeding in MI Patients

Todd Neale

March 14, 2015

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2014

Caitlin E. Cox

January 12, 2015

News Features

Despite New Findings, Optimal DAPT Duration Still Up in the Air

Todd Neale

December 10, 2014

News Daily News

Meta Análisis: La Dosis de Carga con Tienopiridinas No es Necesaria en Pacientes SCASEST

Caitlin E. Cox

November 17, 2014

News Daily News

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

September 02, 2014

News Daily News

HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles

Yael L. Maxwell

July 17, 2014

News Daily News

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

May 20, 2014

News Daily News

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Caitlin E. Cox

April 11, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Daily News

STEMI Patients with Large Thrombus Benefit from Low-dose Thrombolysis

Yael L. Maxwell

April 10, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2013

Jason Kahn

January 27, 2014

News Daily News

Transradial Approach May Balance Bleeding Benefits of Bivalirudin in Primary PCI

Jason Kahn

January 15, 2014

News Daily News

Radial PCI Plus Bivalirudin Effective in Lowering Bleeding Risk

L.A. McKeown

August 19, 2013

News Daily News

PARADOX Published: Smokers’ Paradox Seen with Clopidogrel But not Prasugrel

Caitlin E. Cox

May 13, 2013

News Daily News

PARADOX Publicado: La Paradoja del Fumador se observa con el Clopidogrel pero No con el Prasugrel

Caitlin E. Cox

May 13, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

Advertisement

FDA approves new antiplatelet drug used during heart procedure

Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

Long-Term DAPT with Ticagrelor Reduces Ischemic Risk, Ups Bleeding in MI Patients

TCTMD’s Top 10 Most Popular News Stories for 2014

Despite New Findings, Optimal DAPT Duration Still Up in the Air

Meta Análisis: La Dosis de Carga con Tienopiridinas No es Necesaria en Pacientes SCASEST

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

STEMI Patients with Large Thrombus Benefit from Low-dose Thrombolysis

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

TCTMD’s Top 10 Most Popular News Stories for 2013

Transradial Approach May Balance Bleeding Benefits of Bivalirudin in Primary PCI

Radial PCI Plus Bivalirudin Effective in Lowering Bleeding Risk

PARADOX Published: Smokers’ Paradox Seen with Clopidogrel But not Prasugrel

PARADOX Publicado: La Paradoja del Fumador se observa con el Clopidogrel pero No con el Prasugrel

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content